<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">Antiphospholipid syndrome</z:e> (APS) is a <z:e sem="disease" ids="C0559758" disease_type="Disease or Syndrome" abbrv="">multisystem disorder</z:e> characterized by arterial and <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo>, pregnancy morbidity, and neuropsychiatric manifestations </plain></SENT>
<SENT sid="1" pm="."><plain>Antiphospholipid IgG injected intracerebroventricularly (i.c.v.) cause behavioral <z:hpo ids='HP_0000752'>hyperactivity</z:hpo> in mice </plain></SENT>
<SENT sid="2" pm="."><plain>In the present study we investigated the effects of APS whole-serum i.c.v. administration in female Balb/C mice </plain></SENT>
<SENT sid="3" pm="."><plain>Control mice were injected with serum derived from healthy subjects or saline solution </plain></SENT>
<SENT sid="4" pm="."><plain>Behavior was assessed by the staircase apparatus which combines locomotor (stair-climbing) exploratory activities and rearing as a measure of <z:hpo ids='HP_0000739'>anxiety</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Mice injected with serum from APS patients or serum from <z:mpath ids='MPATH_458'>normal</z:mpath> subjects showed a trend to an increase in the number of stairs climbed in the APS group </plain></SENT>
<SENT sid="6" pm="."><plain>The results suggest a differential effect of specific IgG and other serum components in the <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> manifestations of APS </plain></SENT>
</text></document>